Create Medic Co., Ltd.(JP:5187)
Â¥1,091.00-14.00 (-1.27%)
JP:5187
Create Medic Co., Ltd. financials statements
Â¥1,091.00
At close:-14.00 (-1.27%)
Want to see JP:5187 full AI Analyst Report?
Create Medic Co., Ltd. (5187) Ratios
0 Followers
Create Medic Co., Ltd. Ratios
JP:5187's free cash flow for Q3 2026 was ¥0.00. For the 2026 fiscal year, JP:5187's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.03 | 4.49 | 4.29 | 4.31 | 4.50 |
| Quick Ratio | 4.81 | 3.23 | 2.83 | 2.94 | 3.25 |
| Cash Ratio | 2.88 | 2.03 | 1.48 | 1.53 | 1.69 |
| Solvency Ratio | 0.34 | 0.34 | 0.17 | 0.26 | 0.29 |
| Operating Cash Flow Ratio | 0.26 | 0.72 | 0.24 | 0.16 | 0.49 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 2.70 | 0.87 | 0.58 | 1.56 |
| Net Current Asset Value | ¥ 10.41B | ¥ 9.64B | ¥ 8.41B | ¥ 7.99B | ¥ 7.72B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Debt-to-Equity Ratio | 0.05 | 0.06 | 0.05 | 0.05 | 0.06 |
| Debt-to-Capital Ratio | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.23 | 1.27 | 1.29 | 1.28 | 1.27 |
| Debt Service Coverage Ratio | 163.12 | 1.77 | 0.93 | 1.36 | 1.40 |
| Interest Coverage Ratio | 126.89 | 65.60 | 73.16 | 103.65 | 142.17 |
| Debt to Market Cap | 0.09 | 0.10 | 0.10 | 0.10 | 0.09 |
| Interest Debt Per Share | 89.43 | 102.40 | 89.10 | 88.71 | 88.63 |
| Net Debt to EBITDA | -3.10 | -3.13 | -2.39 | -2.38 | -2.48 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.02% | 43.78% | 43.53% | 43.60% | 44.96% |
| EBIT Margin | 7.85% | 8.42% | 7.27% | 7.06% | 8.31% |
| EBITDA Margin | 12.04% | 13.31% | 11.94% | 11.97% | 12.26% |
| Operating Profit Margin | 7.38% | 5.31% | 6.38% | 5.98% | 7.41% |
| Pretax Profit Margin | 7.79% | 8.34% | 7.18% | 7.00% | 8.25% |
| Net Profit Margin | 5.24% | 6.45% | 1.22% | 3.91% | 5.65% |
| Continuous Operations Profit Margin | 5.24% | 6.45% | 1.22% | 3.91% | 5.65% |
| Net Income Per EBT | 67.29% | 77.37% | 17.04% | 55.87% | 68.39% |
| EBT Per EBIT | 105.54% | 156.95% | 112.55% | 116.99% | 111.40% |
| Return on Assets (ROA) | 3.54% | 4.19% | 0.80% | 2.56% | 3.65% |
| Return on Equity (ROE) | 4.37% | 5.34% | 1.03% | 3.28% | 4.64% |
| Return on Capital Employed (ROCE) | 5.55% | 4.09% | 4.93% | 4.60% | 5.59% |
| Return on Invested Capital (ROIC) | 3.73% | 3.01% | 0.80% | 2.45% | 3.64% |
| Return on Tangible Assets | 3.62% | 4.31% | 0.82% | 2.65% | 3.80% |
| Earnings Yield | 8.20% | 10.44% | 1.90% | 6.02% | 7.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.09 | 4.13 | 3.68 | 3.50 | 3.29 |
| Payables Turnover | 10.88 | 9.36 | 14.25 | 8.60 | 9.43 |
| Inventory Turnover | 1.70 | 1.87 | 1.65 | 1.80 | 2.00 |
| Fixed Asset Turnover | 2.89 | 2.69 | 2.34 | 2.39 | 2.30 |
| Asset Turnover | 0.68 | 0.65 | 0.65 | 0.65 | 0.65 |
| Working Capital Turnover Ratio | 1.18 | 1.27 | 1.32 | 1.35 | 1.36 |
| Cash Conversion Cycle | 270.53 | 244.78 | 295.25 | 264.38 | 254.56 |
| Days of Sales Outstanding | 89.24 | 88.43 | 99.31 | 104.16 | 110.82 |
| Days of Inventory Outstanding | 214.84 | 195.36 | 221.57 | 202.66 | 182.46 |
| Days of Payables Outstanding | 33.55 | 39.01 | 25.62 | 42.44 | 38.72 |
| Operating Cycle | 304.08 | 283.79 | 320.87 | 306.83 | 293.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 62.58 | 255.26 | 76.78 | 50.71 | 137.29 |
| Free Cash Flow Per Share | 11.63 | 201.24 | 27.13 | 11.18 | 69.22 |
| Dividend Paid and CapEx Coverage Ratio | 0.71 | 2.73 | 0.89 | 0.66 | 1.31 |
| Capital Expenditure Coverage Ratio | 1.23 | 4.72 | 1.55 | 1.28 | 2.02 |
| Operating Cash Flow Coverage Ratio | 0.71 | 2.52 | 0.87 | 0.58 | 1.56 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.17 | 0.06 | 0.04 | 0.11 |
| Free Cash Flow Yield | 1.13% | 22.02% | 3.04% | 1.27% | 7.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.19 | 9.59 | 52.71 | 16.60 | 13.48 |
| Price-to-Sales (P/S) Ratio | 0.64 | 0.62 | 0.65 | 0.65 | 0.76 |
| Price-to-Book (P/B) Ratio | 0.53 | 0.51 | 0.54 | 0.54 | 0.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 88.32 | 4.54 | 32.87 | 78.68 | 14.14 |
| Price-to-Operating Cash Flow Ratio | 16.41 | 3.58 | 11.62 | 17.35 | 7.13 |
| Price-to-Earnings Growth (PEG) Ratio | -1.05 | 0.02 | -0.77 | -0.61 | 6.76 |
| Enterprise Value Multiple | 2.21 | 1.52 | 3.01 | 3.05 | 3.73 |
| Enterprise Value | 3.62B | 2.63B | 4.53B | 4.50B | 5.34B |
| EV to EBITDA | 2.21 | 1.52 | 3.01 | 3.05 | 3.73 |
| EV to Sales | 0.27 | 0.20 | 0.36 | 0.37 | 0.46 |
| EV to Free Cash Flow | 36.74 | 1.48 | 18.33 | 44.23 | 8.49 |
| EV to Operating Cash Flow | 6.83 | 1.17 | 6.48 | 9.75 | 4.28 |
| Tangible Book Value Per Share | 1878.50 | 1726.72 | 1579.68 | 1548.35 | 1488.03 |
| Shareholders’ Equity Per Share | 1927.93 | 1787.09 | 1641.82 | 1618.35 | 1563.53 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.33 | 0.23 | 0.83 | 0.44 | 0.32 |
| Revenue Per Share | 1607.47 | 1478.44 | 1382.67 | 1354.87 | 1286.28 |
| Net Income Per Share | 84.25 | 95.41 | 16.92 | 53.00 | 72.61 |
| Tax Burden | 0.67 | 0.77 | 0.17 | 0.56 | 0.68 |
| Interest Burden | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 |
| SG&A to Revenue | 0.37 | 0.38 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.74 | 2.07 | 4.54 | 0.55 | 1.29 |
Currency in JPY

